September 28, 2017 / 11:42 PM / a year ago

Pfizer sues Sun Pharmaceuticals to block generic Bosulif

Pfizer Inc has filed a lawsuit seeking to block a generic manufacturer from selling a cheaper version of leukemia drug Bosulif.

In a complaint filed on Thursday in the U.S. District Court for the District of Delaware, Pfizer claimed Sun Pharmaceutical Industries Ltd’s proposed generic would infringe two of its Bosulif patents, which are set to expire in 2025 and 2026.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below